393 related articles for article (PubMed ID: 15138068)
21. Characterization of Plasmodium knowlesi dihydrofolate reductase-thymidylate synthase and sensitivity to antifolates.
Ittarat W; Pornthanakasem W; Mungthin M; Suwandittakul N; Leelayoova S; Tarnchompoo B; Yuthavong Y; Kongkasuriyachai D; Leartsakulpanich U
Parasitol Int; 2018 Dec; 67(6):787-792. PubMed ID: 30114522
[TBL] [Abstract][Full Text] [Related]
22. Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine.
Lindsay DS; Butler JM; Rippey NS; Blagburn BL
Am J Vet Res; 1996 Jan; 57(1):68-72. PubMed ID: 8720241
[TBL] [Abstract][Full Text] [Related]
23. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant.
Sirawaraporn W; Yongkiettrakul S; Sirawaraporn R; Yuthavong Y; Santi DV
Exp Parasitol; 1997 Nov; 87(3):245-52. PubMed ID: 9371090
[TBL] [Abstract][Full Text] [Related]
25. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors.
Yuthavong Y; Yuvaniyama J; Chitnumsub P; Vanichtanankul J; Chusacultanachai S; Tarnchompoo B; Vilaivan T; Kamchonwongpaisan S
Parasitology; 2005 Mar; 130(Pt 3):249-59. PubMed ID: 15796007
[TBL] [Abstract][Full Text] [Related]
26. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
Fohl LM; Roos DS
Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
[TBL] [Abstract][Full Text] [Related]
27. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites.
Hyde JE
Pharmacol Ther; 1990; 48(1):45-59. PubMed ID: 2274577
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence.
Eldin de Pécoulas P; Basco LK; Tahar R; Ouatas T; Mazabraud A
Gene; 1998 Apr; 211(1):177-85. PubMed ID: 9573357
[TBL] [Abstract][Full Text] [Related]
29. Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa.
Ivanetich KM; Santi DV
FASEB J; 1990 Apr; 4(6):1591-7. PubMed ID: 2180768
[TBL] [Abstract][Full Text] [Related]
30. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
Foote SJ; Galatis D; Cowman AF
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
[TBL] [Abstract][Full Text] [Related]
31. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
32. Cancer research: from folate antagonism to molecular targets.
Bertino JR
Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
[TBL] [Abstract][Full Text] [Related]
33. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
34. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
[TBL] [Abstract][Full Text] [Related]
35. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
Fidock DA; Wellems TE
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
38. Cloning and heterologous expression of Plasmodium ovale dihydrofolate reductase-thymidylate synthase gene.
Tirakarn S; Riangrungroj P; Kongsaeree P; Imwong M; Yuthavong Y; Leartsakulpanich U
Parasitol Int; 2012 Jun; 61(2):324-32. PubMed ID: 22234170
[TBL] [Abstract][Full Text] [Related]
39. Thymidylate synthase-dihydrofolate reductase in protozoa.
Ivanetich KM; Santi DV
Exp Parasitol; 1990 Apr; 70(3):367-71. PubMed ID: 2178951
[TBL] [Abstract][Full Text] [Related]
40. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
